CORT
Price
$71.79
Change
+$2.52 (+3.64%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
6.82B
6 days until earnings call
TENX
Price
$5.77
Change
+$0.31 (+5.68%)
Updated
Apr 24, 04:48 PM (EDT)
Capitalization
22.65M
Ad is loading...

CORT vs TENX

Header iconCORT vs TENX Comparison
Open Charts CORT vs TENXBanner chart's image
Corcept Therapeutics
Price$71.79
Change+$2.52 (+3.64%)
Volume$30.12K
Capitalization6.82B
Tenax Therapeutics
Price$5.77
Change+$0.31 (+5.68%)
Volume$100
Capitalization22.65M
CORT vs TENX Comparison Chart
Loading...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CORT vs. TENX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CORT is a Hold and TENX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (CORT: $69.27 vs. TENX: $5.46)
Brand notoriety: CORT and TENX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CORT: 111% vs. TENX: 59%
Market capitalization -- CORT: $6.82B vs. TENX: $22.65M
CORT [@Biotechnology] is valued at $6.82B. TENX’s [@Biotechnology] market capitalization is $22.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CORT’s FA Score shows that 2 FA rating(s) are green whileTENX’s FA Score has 1 green FA rating(s).

  • CORT’s FA Score: 2 green, 3 red.
  • TENX’s FA Score: 1 green, 4 red.
According to our system of comparison, CORT is a better buy in the long-term than TENX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CORT’s TA Score shows that 5 TA indicator(s) are bullish while TENX’s TA Score has 5 bullish TA indicator(s).

  • CORT’s TA Score: 5 bullish, 5 bearish.
  • TENX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TENX is a better buy in the short-term than CORT.

Price Growth

CORT (@Biotechnology) experienced а +7.23% price change this week, while TENX (@Biotechnology) price change was +0.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

CORT is expected to report earnings on Jul 30, 2025.

TENX is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORT($6.82B) has a higher market cap than TENX($22.7M). CORT YTD gains are higher at: 37.468 vs. TENX (-11.793). CORT has higher annual earnings (EBITDA): 138M vs. TENX (-14.53M). CORT has more cash in the bank: 383M vs. TENX (98.3M). TENX has less debt than CORT: TENX (279K) vs CORT (6.94M). CORT has higher revenues than TENX: CORT (675M) vs TENX (0).
CORTTENXCORT / TENX
Capitalization6.82B22.7M30,062%
EBITDA138M-14.53M-950%
Gain YTD37.468-11.793-318%
P/E Ratio52.59N/A-
Revenue675M0-
Total Cash383M98.3M390%
Total Debt6.94M279K2,486%
FUNDAMENTALS RATINGS
CORT vs TENX: Fundamental Ratings
CORT
TENX
OUTLOOK RATING
1..100
2851
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
10
Undervalued
PROFIT vs RISK RATING
1..100
33100
SMR RATING
1..100
4093
PRICE GROWTH RATING
1..100
3660
P/E GROWTH RATING
1..100
5100
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TENX's Valuation (10) in the Medical Specialties industry is significantly better than the same rating for CORT (82) in the Pharmaceuticals Other industry. This means that TENX’s stock grew significantly faster than CORT’s over the last 12 months.

CORT's Profit vs Risk Rating (33) in the Pharmaceuticals Other industry is significantly better than the same rating for TENX (100) in the Medical Specialties industry. This means that CORT’s stock grew significantly faster than TENX’s over the last 12 months.

CORT's SMR Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for TENX (93) in the Medical Specialties industry. This means that CORT’s stock grew somewhat faster than TENX’s over the last 12 months.

CORT's Price Growth Rating (36) in the Pharmaceuticals Other industry is in the same range as TENX (60) in the Medical Specialties industry. This means that CORT’s stock grew similarly to TENX’s over the last 12 months.

CORT's P/E Growth Rating (5) in the Pharmaceuticals Other industry is significantly better than the same rating for TENX (100) in the Medical Specialties industry. This means that CORT’s stock grew significantly faster than TENX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CORTTENX
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 28 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
66%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SVIX11.760.44
+3.89%
-1x Short VIX Futures ETF
EET51.171.21
+2.43%
ProShares Ultra MSCI Emerging Markets
IGTR23.650.43
+1.85%
Innovator Gradient Tactical Rot Str ETF
CGUS31.820.51
+1.63%
Capital Group Core Equity ETF
USCI70.01-0.19
-0.26%
United States Commodity Index

TENX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TENX has been loosely correlated with AVXL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TENX jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TENX
1D Price
Change %
TENX100%
+7.06%
AVXL - TENX
47%
Loosely correlated
+0.87%
SBHMY - TENX
42%
Loosely correlated
N/A
CORT - TENX
41%
Loosely correlated
+7.10%
ADVM - TENX
36%
Loosely correlated
-3.72%
LOGC - TENX
33%
Loosely correlated
+1.23%
More